November 25, 2020
Business News

Seres Therapeutics Expands Executive Team with Appointments of David S. Ege, Ph.D., as Chief Technology Officer and Jayne M. Gansler as Chief People Officer


CAMBRIDGE, Mass.–()–Seres Therapeutics, Inc. (Nasdaq: MCRB) today announced the expansion of its leadership team with the appointments of David S. Ege, Ph.D., as Executive Vice President, Chief Technology Officer (CTO) and Jayne M. Gansler as Executive Vice President, Chief People Officer (CPO).

“Supported by our highly positive SER-109 Phase 3 results, we are expanding our capabilities and strengthening the Seres team as we move towards what we expect to be the first-ever FDA-approved microbiome therapy. We have taken meaningful steps to prepare for our anticipated growth into a commercial-stage enterprise. Earlier this year, we appointed Lisa von Moltke, M.D., FCP, as Seres’ Chief Medical Officer and Terri…



Click here to view the original article.

Related Posts

You might also like ...

AON Splash Image
What Canadians Think: Clear Seas Releases Its Survey of Attitudes of Canadians Toward Marine Shipping November 30, 2020
Black Friday Nikon Z6 & Z7 Deals 2020 Rated by Saver Trends
California’s Directing Change Program and Film Contest Announces October Winners of Hope and Justice Category